You are here

Article Text

Article menu
Download PDFPDF
Education in Heart
Endothelin antagonism in pulmonary hypertension, heart failure, and beyond

https://doi.org/10.1136/hrt.2004.053991

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Competing interest statement: Professor Webb has, in the past, provided advice to pharmaceutical companies (Abbott, Actelion, Astra Zeneca, BMS, Encysive, Roche) on the clinical development of endothelin antagonists for cardiovascular disease.

    Linked Articles

    • Miscellanea
      WEB TOP 10
      BMJ Publishing Group Ltd and British Cardiovascular Society
      Heart 2005; 91 1089-1089 Published Online First: 14 Jul 2005.